Exact Mass: 715.2112242000001
Exact Mass Matches: 715.2112242000001
Found 16 metabolites which its exact mass value is equals to given mass value 715.2112242000001
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
ADP-Ribosyl-L-arginine
C21H35N9O15P2 (715.1727780000001)
ADP-Ribosyl-L-arginine is the substrate of the protein ADP-ribosylarginine hydrolase (EC-Number 3.2.2.19 ), removing ADP-ribose from arginine residues in ADP ribosylated proteins. Arginine residues in proteins act as acceptors, catalyzing the NAD (+)-dependent activation of the enzyme adenylate cyclase (EC 4.6.1.1). (MetaCyc) [HMDB] ADP-Ribosyl-L-arginine is the substrate of the protein ADP-ribosylarginine hydrolase (EC-Number 3.2.2.19 ), removing ADP-ribose from arginine residues in ADP ribosylated proteins. Arginine residues in proteins act as acceptors, catalyzing the NAD (+)-dependent activation of the enzyme adenylate cyclase (EC 4.6.1.1). (MetaCyc).
acetonitrile,cyclohexa-1,3-dien-1-yl-[(4R,5R)-5-[hydroxy(diphenyl)methyl]-2,2-dimethyl-1,3-dioxolan-4-yl]-phenylmethanol,dichlorotitanium,1,2-dimethoxyethane
C37H43Cl2NO6Ti (715.1946747999999)
Neladenoson dalanate
C35H34ClN7O4S2 (715.1802114000001)
C78274 - Agent Affecting Cardiovascular System
(2S)-2-amino-5-[[amino-[[(3R,4S,5R)-5-[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxymethyl]-3,4-dihydroxyoxolan-2-yl]amino]methylidene]amino]pentanoic acid
C21H35N9O15P2 (715.1727780000001)
(2S)-2-[[(4S)-4-[[(4S)-4-[[4-[(6aR)-3-amino-1-oxo-2,5,6,6a,7,9-hexahydroimidazo[1,5-f]pteridin-8-yl]benzoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]pentanedioic acid
Nomega-(ADP-D-ribosyl)-L-arginine
C21H35N9O15P2 (715.1727780000001)
Ifenprodil (tartrate)
C21H27NO2.1/2C4H6O6 (715.2206058)
Ifenprodil tartrate is a typical noncompetitive NMDA receptor antagonist. Ifenprodil tartrate exerts high affinity at NR1A/NR2B receptors (IC50=0.34 μM) over 400-fold than at NR1A/NR2A receptors (IC50=146 μM)[1]. Ifenprodil tartrate inhibits GIRK (Kir3), reduces inward currents through the basal GIRK activity. Ifenprodil tartrate has the potential to be a cerebral vasodilator[2]. Ifenprodil tartrate is a typical noncompetitive NMDA receptor antagonist. Ifenprodil tartrate exerts high affinity at NR1A/NR2B receptors (IC50=0.34 μM) over 400-fold than at NR1A/NR2A receptors (IC50=146 μM)[1]. Ifenprodil tartrate inhibits GIRK (Kir3), reduces inward currents through the basal GIRK activity. Ifenprodil tartrate has the potential to be a cerebral vasodilator[2].
5,12,14-tris(acetyloxy)-10-[3-(acetyloxy)phenyl]-19-azahexacyclo[20.2.2.1⁸,¹⁹.0²,⁷.0¹⁰,¹⁸.0¹¹,¹⁶]heptacosa-1(25),2,4,6,8(27),11,13,15,22(26),23-decaen-24-yl acetate
6-{[4,5-bis(acetyloxy)-2-[(5-hydroxy-6-{[4-hydroxy-2-(1-hydroxyethyl)pyrrolidin-3-yl]oxy}-2-(hydroxymethyl)-4-methoxyoxan-3-yl)oxy]oxan-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid
(2s)-2-{[hydroxy({2-hydroxy-4-[4-(2-hydroxy-4-methoxy-6-methylbenzoyloxy)-2-methyl-6-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoyloxy]-6-methylphenyl})methylidene]amino}propanoic acid
C34H37NO16 (715.2112242000001)
2-{[hydroxy({2-hydroxy-4-[4-(2-hydroxy-4-methoxy-6-methylbenzoyloxy)-2-methyl-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoyloxy]-6-methylphenyl})methylidene]amino}propanoic acid
C34H37NO16 (715.2112242000001)